A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

Author: Anis Aslam H.   Sun Huiying  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.24, Iss.4, 2006-01, pp. : 387-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract